| 摘要 |
<p>Provided herein are methods for treating or preventing drug-resistant hepatitis C virus infection in a subject, which comprises administering to the subject a 5,5-fused heteroarylene hepatitis C virus inhibitor compound, for example, of Formula I, IA, or IB.</p> |
| 申请人 |
IDENIX PHARMACEUTICALS, INC. |
发明人 |
DOUSSON, CYRIL, B.;DUKHAN, DAVID;PARSY, CHRISTOPHER, CLAUDE;PIERRA, CLAIRE;ALEXANDRE, FRANCOIS-RENE;BRANDT, GUILLAUME;DA COSTA, DANIEL;RAHALI, HOUCINE;PAPARIN, JEAN-LAURENT;DEROCK, MICHEL;CONVARD, THIERRY;SURLERAUX, DOMINIQUE;BILELLO, JOHN, P. |
